Team

Robert Joined Truffle Capital in April 2020. He has more than 20 years of experience in the Pharmaceutical and Biotech Industry. Scientist by formation, Robert has project led a number of projects from the initial idea all the way to phase 2 clinical trials -proof of concept studies. Robert has since contributed to a large number of pharma related transactions as Director of Business Development and Licensing at Roche, as head of Asia Pacific Global External R&D at Eli Lilly China and more recently through its own consulting firm. Robert graduated with a PhD in Chemistry from Glasgow, UK, a post-doc from Harvard University and an MBA from the London Business School.